New Delhi, June 17: The Indian pharmaceutical market recorded a 12 percent year-on-year growth in May, according to a recent industry report, reflecting continued strength in demand across key therapeutic segments.
The report indicates that growth was driven by steady consumption of medicines in areas such as chronic therapies, acute care, and seasonal treatments. Increased healthcare access and sustained prescription demand also contributed to the overall expansion of the market.
Industry observers noted that the sector continues to benefit from improving healthcare awareness, expanding distribution networks, and consistent demand from both urban and rural markets.
The pharmaceutical industry in India remains one of the most resilient sectors, supported by strong domestic consumption as well as its global presence in generic medicine supply chains.
Experts suggest that while short-term fluctuations may occur, the overall outlook for the sector remains positive, backed by structural growth drivers such as population needs, healthcare expansion, and innovation in drug development.
The report concludes that the steady 12 percent growth highlights the continued importance of the pharmaceutical sector in India’s healthcare and economic landscape.